Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Drugs|September 5, 2024
Impact of CYP2C19 Genotype Status on Clinical Outcomes in Patients with Symptomatic Coronary Artery Disease, Stroke, and Peripheral Arterial Disease: A Systematic Review and Meta-AnalysisDominique P M S M Maas, Loes H Willems, Josephine Kranendonk, et al.Journal of Thrombosis and Haemostasis : JTH|January 17, 2022
Treatment of patients with rare bleeding disorders in the Netherlands: Real-life data from the RBiN studyDominique P M S M Maas, Joline L Saes, Nicole M A Blijlevens, et al.Drugs|August 23, 2022
Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-AnalysisLoes H Willems, Dominique P M S M Maas, Kees Kramers, et al.Journal of Thrombosis and Haemostasis : JTH|July 30, 2023
High prevalence of heavy menstrual bleeding in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN studyDominique P M S M Maas, Joline L Saes, Nicole M A Blijlevens, et al.Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
High prevalence of postpartum hemorrhage in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN studyDominique P M S M Maas, Joline L Saes, Nicole M A Blijlevens, et al.Journal of Thrombosis and Haemostasis : JTH|November 10, 2021
Von Willebrand disease type 2M: Correlation between genotype and phenotypeDominique P M S M Maas, Ferdows Atiq, Nicole M A Blijlevens, et al.Journal of Thrombosis and Haemostasis : JTH|March 8, 2025
Bleeding symptoms in persons with rare bleeding disorders and a heterozygous genotype: data from the Rare Bleeding Disorders in the Netherlands studySterre P E Willems, Marjon H Cnossen, Nick van Es, et al.Blood Advances|April 21, 2022
Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand diseaseFerdows Atiq, Jessica Heijdra, Fleur Snijders, et al.Pageof 1